Werewolf Therapeutics, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: HOWL
Werewolf Therapeutics, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker HOWL. It has reported private securities offerings to the US SEC, most recently $72 million sold in a notice filed in 2021.
Werewolf Therapeutics at a glance
What does Werewolf Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $72.1 million sold (2021).
Frequently asked questions about Werewolf Therapeutics
Where is Werewolf Therapeutics headquartered?
Werewolf Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Werewolf Therapeutics do?
Werewolf Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Werewolf Therapeutics a public company?
Yes. Werewolf Therapeutics, Inc. trades on Nasdaq under the ticker HOWL.
When was Werewolf Therapeutics founded?
The earliest incorporation on record for Werewolf Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.